James McCullough | executive |
Fergus Fleming | executive |
Daniel Arias | analyst |
Oliver Sterling | executive |
Randy Baron | analyst |
Howard Doran | executive |
Mark Massaro | analyst |
Jens Lindqvist | analyst |
Good morning, and welcome to the Renalytix conference call to review Third Quarter Fiscal Year 2024 Financial Results. [Operator Instructions].
As a reminder, this call is being recorded for replay purposes.
I would now like to turn the call over to Peter DeNardo of Capcomm Partners for a few introductory comments.
Thank you, Olivia.